Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Imbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Patients with Cardiac Ischemia and Chronic Stable Angina
11/13/2023

Imbria Pharmaceuticals, Inc. News

Imbria Pharmaceuticals, Inc. News ...
At 8 weeks, treatment with ninerafaxstat demonstrated clinically and statistically significant improvements in dobutamine stress-induced ischemic left ventricular (LV) wall motion abnormalities.
At 8 weeks, treatment with ninerafaxstat demonstrated clinically and statistically significant improvements in dobutamine stress-induced ischemic left ventricular (LV) wall motion abnormalities.
At 8 weeks, treatment with...
11/13/2023
Cath Lab Digest
News
IND for TNX-103 (oral levosimendan) Receives FDA Clearance for Treatment of Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction
11/13/2023

Tenax Therapeutics, Inc. News

Tenax Therapeutics, Inc. News
CHAPEL HILL, N.C.-- Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced that...
CHAPEL HILL, N.C.-- Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced that...
CHAPEL HILL, N.C.-- Tenax...
11/13/2023
Cath Lab Digest

Advertisement

News
AHA's Risk Calculator, PREVENT (Predicting Risk of cardiovascular disease EVENTs), Estimates Heart Attack, Stroke and Heart Failure Risk
11/13/2023

American Heart Association News

American Heart Association News ...
The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex. As more research has been conducted specifically in women, this is an important way to understand their unique differences in CVD presentation and risk...
The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex. As more research has been conducted specifically in women, this is an important way to understand their unique differences in CVD presentation and risk...
The PREVENT risk calculator...
11/13/2023
Cath Lab Digest
News
Canadian Cardiovascular Society Classification of Acute Myocardial Infarction (CCS-AMI): A Classification of 4 Stages of Heart Attack Based on Myocardial Damage
11/13/2023

Elsevier News

Elsevier News
This expert consensus offers a more differentiated definition of heart attacks and improves the understanding of acute atherothrombotic myocardial infarction.
This expert consensus offers a more differentiated definition of heart attacks and improves the understanding of acute atherothrombotic myocardial infarction.
This expert consensus offers a...
11/13/2023
Cath Lab Digest
News
New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women and Men
11/09/2023

Shockwave Medical News

Shockwave Medical News
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
In the patient-level pooled...
11/09/2023
Cath Lab Digest

Advertisement

FDA Approval
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
11/08/2023

Recor Medical News

Recor Medical News
The RADIANCE global program studied the Paradise system in three independently powered, sham-controlled, randomized clinical trials in over 500 patients with uncontrolled hypertension.
The RADIANCE global program studied the Paradise system in three independently powered, sham-controlled, randomized clinical trials in over 500 patients with uncontrolled hypertension.
The RADIANCE global program...
11/08/2023
Cath Lab Digest
News
Standing Blood Pressure Test More Accurate in Detecting Hypertension
11/07/2023

UT Southwestern Medical Center News

UT Southwestern Medical Center News ...
DALLAS – Measuring blood pressure while patients are standing rather than sitting may improve the accuracy of readings, UT Southwestern Medical Center researchers report. Their findings, published in Scientific Reports, could lead...
DALLAS – Measuring blood pressure while patients are standing rather than sitting may improve the accuracy of readings, UT Southwestern Medical Center researchers report. Their findings, published in Scientific Reports, could lead...
DALLAS – Measuring blood...
11/07/2023
Cath Lab Digest
News
Imbria Reports Positive Topline Results for Investigational Drug Ninerafaxstat in Patients With Non-Obstructive Hypertrophic Cardiomyopathy
11/07/2023

Imbria Pharmaceuticals, Inc. News

Imbria Pharmaceuticals, Inc. News ...
At 12-weeks, treatment with ninerafaxstat showed a statistically significant improvement in a robust functional cardiopulmonary exercise test (CPET) measure of established prognostic significance in patients with nHCM and heart failure with...
At 12-weeks, treatment with ninerafaxstat showed a statistically significant improvement in a robust functional cardiopulmonary exercise test (CPET) measure of established prognostic significance in patients with nHCM and heart failure with...
At 12-weeks, treatment with...
11/07/2023
Cath Lab Digest

Advertisement

News
CIS Is First in the State to Use Auryon Atherectomy System in a Hospital Setting to Treat Peripheral Artery Disease
11/06/2023
  ZACHARY, LA– Dr. Charles Thompson, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Auryon Laser Atherectomy System by AngioDynamics, Inc. in a hospital setting to...
  ZACHARY, LA– Dr. Charles Thompson, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Auryon Laser Atherectomy System by AngioDynamics, Inc. in a hospital setting to...
  ZACHARY, LA– Dr....
11/06/2023
Vascular Disease Management
News
VIVA23: Prof. Thomas Zeller Presents One-Year Results of DEEPER OUS Clinical Trial of Reflow Medical's Bare Temporary Spur Stent System
11/06/2023

Reflow Medical News

Reflow Medical News
The 107-patient, prospective, non-randomized, multicenter, single-arm study evaluates the Bare Temporary Spur Stent System in combination with a paclitaxel-coated balloon in patients with below-the-knee arterial disease.
The 107-patient, prospective, non-randomized, multicenter, single-arm study evaluates the Bare Temporary Spur Stent System in combination with a paclitaxel-coated balloon in patients with below-the-knee arterial disease.
The 107-patient, prospective,...
11/06/2023
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use